Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2017 1
2018 2
2019 4
2020 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, Sillano F, Buttarelli M, Piermattei A, Loverro M, Camarda F, Greco V, De Bonis M, Minucci A, Gallo D, Urbani A, Vizzielli G, Scambia G, Sette C. Cesari E, et al. Among authors: pieraccioli m. J Exp Clin Cancer Res. 2023 May 18;42(1):126. doi: 10.1186/s13046-023-02682-5. J Exp Clin Cancer Res. 2023. PMID: 37202753 Free PMC article.
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.
Ruta V, Naro C, Pieraccioli M, Leccese A, Archibugi L, Cesari E, Panzeri V, Allgöwer C, Arcidiacono PG, Falconi M, Carbone C, Tortora G, Borrelli F, Attili F, Spada C, Quero G, Alfieri S, Doglioni C, Kleger A, Capurso G, Sette C. Ruta V, et al. Among authors: pieraccioli m. Cell Rep Med. 2024 Feb 20;5(2):101411. doi: 10.1016/j.xcrm.2024.101411. Epub 2024 Feb 6. Cell Rep Med. 2024. PMID: 38325381 Free PMC article.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Travaglini S, Ottone T, Angelini DF, Fiori V, Dominici S, Noguera NI, Śniegocka M, Antonelli S, Irno Consalvo MA, De Bardi M, Banella C, Divona M, Marchesi F, Masciarelli S, Fazi F, Pieraccioli M, Palmieri R, De Angelis G, Buccisano F, Venditti A, Battistini L, Magnani M, Voso MT. Travaglini S, et al. Among authors: pieraccioli m. Leukemia. 2022 Jun;36(6):1685-1688. doi: 10.1038/s41375-022-01566-5. Epub 2022 Apr 14. Leukemia. 2022. PMID: 35422094 No abstract available.
ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.
Nicolai S, Pieraccioli M, Smirnov A, Pitolli C, Anemona L, Mauriello A, Candi E, Annicchiarico-Petruzzelli M, Shi Y, Wang Y, Melino G, Raschellà G. Nicolai S, et al. Among authors: pieraccioli m. Mol Oncol. 2020 Feb;14(2):294-308. doi: 10.1002/1878-0261.12605. Epub 2019 Dec 24. Mol Oncol. 2020. PMID: 31782884 Free PMC article.
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Falconi G, Galossi E, Fabiani E, Pieraccioli M, Travaglini S, Hajrullaj H, Cerretti R, Palmieri R, Latagliata R, Maurillo L, Voso MT. Falconi G, et al. Among authors: pieraccioli m. Sci Rep. 2022 Dec 8;12(1):21231. doi: 10.1038/s41598-022-24644-1. Sci Rep. 2022. PMID: 36481766 Free PMC article.
19 results